Gutry Phil
- SEC CIK
- 0001653224
No open-market purchases or sales filed in the past year.
Current role at each company
- LENZ LENZ Therapeutics, Inc.CHIEF BUSINESS OFFICERas of Apr 13, 2022
- AVTX Avalo Therapeutics, Inc.Directoras of Dec 3, 2021
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- –
- 0 filings
- Net
- –
- Bought minus sold
- Companies
- 0
- With open-market trades
Trades
Every Form 4 that lists Gutry Phil as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
LENZ LENZ Therapeutics, Inc.
CHIEF BUSINESS OFFICER1 trade
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Apr 13, 2022 (view filing) | Apr 11 | 2 days | Gutry PhilCHIEF BUSINESS OFFICER | PPurchase | +5.00K | $4.01 | +$20.1K | +1.7%299.9K after |